Mohit Bansal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohit Bansal has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Han-Fei Ding
University of Alabama at Birmingham 1 Department of Pathology, Heersink School of Medicine Birmingham, Alabama
8 shared publications - Jane Ding
University of Alabama at Birmingham 1 Department of Pathology, Heersink School of Medicine Birmingham, Alabama
8 shared publications - Sunil Sudarshan
Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama, USA
8 shared publications - Anamika Gupta
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
7 shared publications - Bingwei Ye
Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, Georgia
6 shared publications - Rui Mao
Georgia Cancer Center, Medical College of Georgia, Augusta University
6 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
- p. OF1-OF15
Impaired Mevalonate-Dependent NAD+ Regeneration Suppresses Serine Biosynthesis and Enhances Sensitivity to PHGDH Inhibition
The mevalonate (MVA) pathway generates sterols and isoprenoids essential for membrane biosynthesis and signaling. Increased activity of the MVA pathway is a common feature of cancer and has emerged as a potential therapeutic vulnerability. In this study, we showed that the MVA pathway sustains de novo serine biosynthesis and aspartate production by maintaining NAD+ regeneration through ubiquinone-dependent electron transport. Statin-mediated inhibition of the MVA pathway impaired oxidative phosphorylation, lowered the NAD+/NADH ratio, suppressed serine and aspartate biosynthesis, and activated the GCN2–eIF2α–ATF4 amino acid deprivation response. The resulting depletion of serine-derived glycine and one-carbon units, together with reduced aspartate availability, limited purine and pyrimidine biosynthesis. Genetic and pharmacologic disruption of ubiquinone synthesis recapitulated the metabolic defects, whereas expression of the bacterial NADH oxidase Lactobacillus brevis NADH oxidase restored the NAD+/NADH ratio and reversed the metabolic and growth defects induced by statin treatment. Importantly, impairment of NAD+ regeneration reduced phosphoglycerate dehydrogenase (PHGDH)–dependent de novo serine synthesis, thereby sensitizing neuroblastoma cells to PHGDH inhibition. Accordingly, simvastatin enhanced the antiproliferative effects of the PHGDH inhibitor NCT-503 in vitro and exhibited elevated antitumor activity in combination with NCT-503 in neuroblastoma xenograft models. Together, these findings establish ubiquinone-dependent NAD+ regeneration as a key mechanism linking the MVA pathway to amino acid and nucleotide biosynthesis and provide a mechanistic rationale for combined targeting of the MVA pathway and serine biosynthesis in cancer. Significance: The mevalonate pathway functions as a regulator of amino acid and nucleotide biosynthesis through mitochondrial NAD+ regeneration, providing a rationale for targeting mevalonate metabolism and serine biosynthesis in cancer.
- 21 October 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
- p. OF1-OF15
Open AccessImpaired Mevalonate-Dependent NAD+ Regeneration Suppresses Serine Biosynthesis and Enhances Sensitivity to PHGDH Inhibition
The mevalonate (MVA) pathway generates sterols and isoprenoids essential for membrane biosynthesis and signaling. Increased activity of the MVA pathway is a common feature of cancer and has emerged as a potential therapeutic vulnerability. In this study, we showed that the MVA pathway sustains de novo serine biosynthesis and aspartate production by maintaining NAD+ regeneration through ubiquinone-dependent electron transport. Statin-mediated inhibition of the MVA pathway impaired oxidative phosphorylation, lowered the NAD+/NADH ratio, suppressed serine and aspartate biosynthesis, and activated the GCN2–eIF2α–ATF4 amino acid deprivation response. The resulting depletion of serine-derived glycine and one-carbon units, together with reduced aspartate availability, limited purine and pyrimidine biosynthesis. Genetic and pharmacologic disruption of ubiquinone synthesis recapitulated the metabolic defects, whereas expression of the bacterial NADH oxidase Lactobacillus brevis NADH oxidase restored the NAD+/NADH ratio and reversed the metabolic and growth defects induced by statin treatment. Importantly, impairment of NAD+ regeneration reduced phosphoglycerate dehydrogenase (PHGDH)–dependent de novo serine synthesis, thereby sensitizing neuroblastoma cells to PHGDH inhibition. Accordingly, simvastatin enhanced the antiproliferative effects of the PHGDH inhibitor NCT-503 in vitro and exhibited elevated antitumor activity in combination with NCT-503 in neuroblastoma xenograft models. Together, these findings establish ubiquinone-dependent NAD+ regeneration as a key mechanism linking the MVA pathway to amino acid and nucleotide biosynthesis and provide a mechanistic rationale for combined targeting of the MVA pathway and serine biosynthesis in cancer. Significance: The mevalonate pathway functions as a regulator of amino acid and nucleotide biosynthesis through mitochondrial NAD+ regeneration, providing a rationale for targeting mevalonate metabolism and serine biosynthesis in cancer.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Table S1. primers and oligonucleotides. Table S2. Microarray gene expression profiling (shPUS7-33 vs shGFP). Table S3. Functional annotation of PUS7 knockdown-responsive genes. Table S4. 13C-glucose metabolic flux analysis. Table S5. 13C-15N-glutamine metabolic flux analysis. Table S6. Nanopore RNA seq - MCTS1 mRNA Y modification. Table S7. Proteomic analysis of proteins downregulated by PUS7 knockdown in BE(2)-C cells. Table S8. Polysome enrichment of transcripts with higher levels of pseudouridylation. Table S9. Nanopore RNA seq - ATF4 mRNA Y modification
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Table S1. primers and oligonucleotides. Table S2. Microarray gene expression profiling (shPUS7-33 vs shGFP). Table S3. Functional annotation of PUS7 knockdown-responsive genes. Table S4. 13C-glucose metabolic flux analysis. Table S5. 13C-15N-glutamine metabolic flux analysis. Table S6. Nanopore RNA seq - MCTS1 mRNA Y modification. Table S7. Proteomic analysis of proteins downregulated by PUS7 knockdown in BE(2)-C cells. Table S8. Polysome enrichment of transcripts with higher levels of pseudouridylation. Table S9. Nanopore RNA seq - ATF4 mRNA Y modification
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Figure S1. PUS7 is a direct transcriptional target of MYC oncoproteins. Figure S2. High PUS7 expression is associated with poor prognosis and is required for the proliferation and tumorigenicity MYC-driven cancer cells. Figure S3. Functional annotation of PUS7 target genes. Figure S4. PUS7 sustains amino acid biosynthesis and adaptive stress responses. Figure S5. PUS7 protects cells from MYCN-induced cellular stress by enabling ATF4-mediated adaptive responses. Figure S6. PUS7 targets MCTS1 to sustain ATF4 mRNA translation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Figure S1. PUS7 is a direct transcriptional target of MYC oncoproteins. Figure S2. High PUS7 expression is associated with poor prognosis and is required for the proliferation and tumorigenicity MYC-driven cancer cells. Figure S3. Functional annotation of PUS7 target genes. Figure S4. PUS7 sustains amino acid biosynthesis and adaptive stress responses. Figure S5. PUS7 protects cells from MYCN-induced cellular stress by enabling ATF4-mediated adaptive responses. Figure S6. PUS7 targets MCTS1 to sustain ATF4 mRNA translation.
- Open Access
- 29 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (35) , eadv9401
DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation
The pseudouridine synthase DKC1 regulates internal ribosome entry site (IRES)–dependent translation and is up-regulated in cancers by the MYC family of oncogenes. The functional significance of DKC1 up-regulation and the mechanistic connection between pseudouridylation and IRES-mediated translation remain poorly understood. Here, we report that DKC1 drives an ATF4-mediated transcriptional program that supports amino acid metabolism and stress adaptation. We identify hnRNP A1, an IRES trans-acting factor, as a critical downstream mediator of DKC1 in sustaining ATF4 expression and IRES-dependent translation. Mechanistically, DKC1-mediated pseudouridylation at two specific 28 S ribosomal RNA sites is crucial for maintaining hnRNP A1 protein expression. In turn, hnRNP A1 binds and stabilizes ATF4 messenger RNA, preferentially promoting IRES-dependent translation of ATF4 variant 1. Furthermore, cellular stress induces hnRNP A1, which is necessary for stress-induced ATF4 protein expression. Collectively, our findings uncover an MYC-driven DKC1-hnRNP A1 axis that links IRES-dependent translation and ATF4-mediated metabolic adaptation, thereby supporting cancer cell survival under metabolic stress during tumor progression.
- 29 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (35) , eadv9401
Open AccessDKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation
The pseudouridine synthase DKC1 regulates internal ribosome entry site (IRES)–dependent translation and is up-regulated in cancers by the MYC family of oncogenes. The functional significance of DKC1 up-regulation and the mechanistic connection between pseudouridylation and IRES-mediated translation remain poorly understood. Here, we report that DKC1 drives an ATF4-mediated transcriptional program that supports amino acid metabolism and stress adaptation. We identify hnRNP A1, an IRES trans-acting factor, as a critical downstream mediator of DKC1 in sustaining ATF4 expression and IRES-dependent translation. Mechanistically, DKC1-mediated pseudouridylation at two specific 28 S ribosomal RNA sites is crucial for maintaining hnRNP A1 protein expression. In turn, hnRNP A1 binds and stabilizes ATF4 messenger RNA, preferentially promoting IRES-dependent translation of ATF4 variant 1. Furthermore, cellular stress induces hnRNP A1, which is necessary for stress-induced ATF4 protein expression. Collectively, our findings uncover an MYC-driven DKC1-hnRNP A1 axis that links IRES-dependent translation and ATF4-mediated metabolic adaptation, thereby supporting cancer cell survival under metabolic stress during tumor progression.
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Figure S1. PUS7 is a direct transcriptional target of MYC oncoproteins. Figure S2. High PUS7 expression is associated with poor prognosis and is required for the proliferation and tumorigenicity MYC-driven cancer cells. Figure S3. Functional annotation of PUS7 target genes. Figure S4. PUS7 sustains amino acid biosynthesis and adaptive stress responses. Figure S5. PUS7 protects cells from MYCN-induced cellular stress by enabling ATF4-mediated adaptive responses. Figure S6. PUS7 targets MCTS1 to sustain ATF4 mRNA translation.
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Figure S1. PUS7 is a direct transcriptional target of MYC oncoproteins. Figure S2. High PUS7 expression is associated with poor prognosis and is required for the proliferation and tumorigenicity MYC-driven cancer cells. Figure S3. Functional annotation of PUS7 target genes. Figure S4. PUS7 sustains amino acid biosynthesis and adaptive stress responses. Figure S5. PUS7 protects cells from MYCN-induced cellular stress by enabling ATF4-mediated adaptive responses. Figure S6. PUS7 targets MCTS1 to sustain ATF4 mRNA translation.
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Tables from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Table S1. primers and oligonucleotides. Table S2. Microarray gene expression profiling (shPUS7-33 vs shGFP). Table S3. Functional annotation of PUS7 knockdown-responsive genes. Table S4. 13C-glucose metabolic flux analysis. Table S5. 13C-15N-glutamine metabolic flux analysis. Table S6. Nanopore RNA seq - MCTS1 mRNA Y modification. Table S7. Proteomic analysis of proteins downregulated by PUS7 knockdown in BE(2)-C cells. Table S8. Polysome enrichment of transcripts with higher levels of pseudouridylation. Table S9. Nanopore RNA seq - ATF4 mRNA Y modification
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Table S1. primers and oligonucleotides. Table S2. Microarray gene expression profiling (shPUS7-33 vs shGFP). Table S3. Functional annotation of PUS7 knockdown-responsive genes. Table S4. 13C-glucose metabolic flux analysis. Table S5. 13C-15N-glutamine metabolic flux analysis. Table S6. Nanopore RNA seq - MCTS1 mRNA Y modification. Table S7. Proteomic analysis of proteins downregulated by PUS7 knockdown in BE(2)-C cells. Table S8. Polysome enrichment of transcripts with higher levels of pseudouridylation. Table S9. Nanopore RNA seq - ATF4 mRNA Y modification
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Data from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Pseudouridylation is a common RNA modification that is catalyzed by the family of pseudouridine synthases (PUS). Pseudouridylation can increase RNA stability and rigidity, thereby impacting RNA splicing, processing, and translation. Given that RNA metabolism is frequently altered in cancer, pseudouridylation may be a functionally important process in tumor biology. Here, we show that the MYC family of oncoproteins transcriptionally upregulates PUS7 expression during cancer development. PUS7 is essential for the growth and survival of MYC-driven cancer cells and xenografts by promoting adaptive stress responses and amino acid biosynthesis and import. ATF4, a master regulator of stress responses and cellular metabolism, was identified as a key downstream mediator of PUS7 functional activity. Induction of ATF4 by MYC oncoproteins and cellular stress required PUS7, and ATF4 overexpression overcame the growth inhibition caused by PUS7 deficiency. Mechanistically, PUS7 induced pseudouridylation of MCTS1 mRNA, which enhanced its translation. MCTS1, a noncanonical translation initiation factor, drove stress-induced ATF4 protein expression. A PUS7 consensus pseudouridylation site in the 3′ untranslated region of ATF4 mRNA was crucial for the induction of ATF4 by cellular stress. These findings unveil an MYC-activated mRNA pseudouridylation program that mitigates cellular stress induced by MYC stimulation of proliferation and biomass production, suggesting that targeting PUS7 could be a therapeutic strategy selectively against MYC-driven cancers.Significance: Oncogene activation of mRNA pseudouridylation is a mechanism that facilitates metabolic reprogramming and adaptive responses to overcome cellular stress during cancer development.
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Pseudouridylation is a common RNA modification that is catalyzed by the family of pseudouridine synthases (PUS). Pseudouridylation can increase RNA stability and rigidity, thereby impacting RNA splicing, processing, and translation. Given that RNA metabolism is frequently altered in cancer, pseudouridylation may be a functionally important process in tumor biology. Here, we show that the MYC family of oncoproteins transcriptionally upregulates PUS7 expression during cancer development. PUS7 is essential for the growth and survival of MYC-driven cancer cells and xenografts by promoting adaptive stress responses and amino acid biosynthesis and import. ATF4, a master regulator of stress responses and cellular metabolism, was identified as a key downstream mediator of PUS7 functional activity. Induction of ATF4 by MYC oncoproteins and cellular stress required PUS7, and ATF4 overexpression overcame the growth inhibition caused by PUS7 deficiency. Mechanistically, PUS7 induced pseudouridylation of MCTS1 mRNA, which enhanced its translation. MCTS1, a noncanonical translation initiation factor, drove stress-induced ATF4 protein expression. A PUS7 consensus pseudouridylation site in the 3′ untranslated region of ATF4 mRNA was crucial for the induction of ATF4 by cellular stress. These findings unveil an MYC-activated mRNA pseudouridylation program that mitigates cellular stress induced by MYC stimulation of proliferation and biomass production, suggesting that targeting PUS7 could be a therapeutic strategy selectively against MYC-driven cancers.Significance: Oncogene activation of mRNA pseudouridylation is a mechanism that facilitates metabolic reprogramming and adaptive responses to overcome cellular stress during cancer development.
- Open Access
- 6 September 2024
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 84 (23) , 4031-4048
MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Pseudouridylation is a common RNA modification that is catalyzed by the family of pseudouridine synthases (PUS). Pseudouridylation can increase RNA stability and rigidity, thereby impacting RNA splicing, processing, and translation. Given that RNA metabolism is frequently altered in cancer, pseudouridylation may be a functionally important process in tumor biology. Here, we show that the MYC family of oncoproteins transcriptionally upregulates PUS7 expression during cancer development. PUS7 is essential for the growth and survival of MYC-driven cancer cells and xenografts by promoting adaptive stress responses and amino acid biosynthesis and import. ATF4, a master regulator of stress responses and cellular metabolism, was identified as a key downstream mediator of PUS7 functional activity. Induction of ATF4 by MYC oncoproteins and cellular stress required PUS7, and ATF4 overexpression overcame the growth inhibition caused by PUS7 deficiency. Mechanistically, PUS7 induced pseudouridylation of MCTS1 mRNA, which enhanced its translation. MCTS1, a noncanonical translation initiation factor, drove stress-induced ATF4 protein expression. A PUS7 consensus pseudouridylation site in the 3′ untranslated region of ATF4 mRNA was crucial for the induction of ATF4 by cellular stress. These findings unveil an MYC-activated mRNA pseudouridylation program that mitigates cellular stress induced by MYC stimulation of proliferation and biomass production, suggesting that targeting PUS7 could be a therapeutic strategy selectively against MYC-driven cancers. Significance: Oncogene activation of mRNA pseudouridylation is a mechanism that facilitates metabolic reprogramming and adaptive responses to overcome cellular stress during cancer development.
- 6 September 2024
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 84 (23) , 4031-4048
Open AccessMYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development
Pseudouridylation is a common RNA modification that is catalyzed by the family of pseudouridine synthases (PUS). Pseudouridylation can increase RNA stability and rigidity, thereby impacting RNA splicing, processing, and translation. Given that RNA metabolism is frequently altered in cancer, pseudouridylation may be a functionally important process in tumor biology. Here, we show that the MYC family of oncoproteins transcriptionally upregulates PUS7 expression during cancer development. PUS7 is essential for the growth and survival of MYC-driven cancer cells and xenografts by promoting adaptive stress responses and amino acid biosynthesis and import. ATF4, a master regulator of stress responses and cellular metabolism, was identified as a key downstream mediator of PUS7 functional activity. Induction of ATF4 by MYC oncoproteins and cellular stress required PUS7, and ATF4 overexpression overcame the growth inhibition caused by PUS7 deficiency. Mechanistically, PUS7 induced pseudouridylation of MCTS1 mRNA, which enhanced its translation. MCTS1, a noncanonical translation initiation factor, drove stress-induced ATF4 protein expression. A PUS7 consensus pseudouridylation site in the 3′ untranslated region of ATF4 mRNA was crucial for the induction of ATF4 by cellular stress. These findings unveil an MYC-activated mRNA pseudouridylation program that mitigates cellular stress induced by MYC stimulation of proliferation and biomass production, suggesting that targeting PUS7 could be a therapeutic strategy selectively against MYC-driven cancers. Significance: Oncogene activation of mRNA pseudouridylation is a mechanism that facilitates metabolic reprogramming and adaptive responses to overcome cellular stress during cancer development.
- 27 April 2017
- Published by Wiley in Zoonoses and Public Health
- Vol. 64 (8) , 662-672
Seroepidemiology and molecular characterization of hepatitis E virus infection in swine and occupationally exposed workers in Punjab, India
Summary: Hepatitis E virus (HEV) has two discrete epidemiological patterns: waterborne epidemics in developing countries only, caused byHEVgenotype I, and sporadic zoonotic outbreaks in developing and developed countries caused by genotypesIIIandIV. This study was designed to investigate seroprevalence, molecular detection and the characterization ofHEVby nestedRT‐PCRin swine as well as the occupational risk to exposed human population in Punjab state of north‐western India. The occupational risk‐exposed group comprised of swine farmers (organized – mixed feed feeders and unorganized – swill feeders), slaughterhouse workers, sewage workers and veterinary internes. During the study period, blood and faecal samples were collected from 320 swine and 360 humans with both high and low occupational exposure risks. The overall seroprevalence of swineHEVwas 65.00%, with a significantly higher seropositivity in growing pigs (2–8 months of age). The prevalence ofHEV RNAin swine faecal samples bynRT‐PCRwas 8.75% with a significantly higher detection in swill‐fed pigs. With humans in the high occupational exposure risk population, significantly higher anti‐HEVIgG seropositivity was observed (60.48%) as compared to control population (10.71%). Strong evidence of association between human anti‐HEVIgG seropositivity and certain occupational exposure risk groups was observed (p < 0.05). This indicates that unorganized swine farmers, slaughterhouse workers and sewage workers have higher odds ofHEVinfection in this study region. Percentage of nucleotide similarity between swine and humanHEVisolates was less than that found in countries with zoonoticHEVoutbreaks. Molecular characterization revealed the circulation of GIVand G I genotypes among swine and human population in Punjab state, respectively.
- 27 April 2017
- Published by Wiley in Zoonoses and Public Health
- Vol. 64 (8) , 662-672
Seroepidemiology and molecular characterization of hepatitis E virus infection in swine and occupationally exposed workers in Punjab, India
Summary: Hepatitis E virus (HEV) has two discrete epidemiological patterns: waterborne epidemics in developing countries only, caused byHEVgenotype I, and sporadic zoonotic outbreaks in developing and developed countries caused by genotypesIIIandIV. This study was designed to investigate seroprevalence, molecular detection and the characterization ofHEVby nestedRT‐PCRin swine as well as the occupational risk to exposed human population in Punjab state of north‐western India. The occupational risk‐exposed group comprised of swine farmers (organized – mixed feed feeders and unorganized – swill feeders), slaughterhouse workers, sewage workers and veterinary internes. During the study period, blood and faecal samples were collected from 320 swine and 360 humans with both high and low occupational exposure risks. The overall seroprevalence of swineHEVwas 65.00%, with a significantly higher seropositivity in growing pigs (2–8 months of age). The prevalence ofHEV RNAin swine faecal samples bynRT‐PCRwas 8.75% with a significantly higher detection in swill‐fed pigs. With humans in the high occupational exposure risk population, significantly higher anti‐HEVIgG seropositivity was observed (60.48%) as compared to control population (10.71%). Strong evidence of association between human anti‐HEVIgG seropositivity and certain occupational exposure risk groups was observed (p < 0.05). This indicates that unorganized swine farmers, slaughterhouse workers and sewage workers have higher odds ofHEVinfection in this study region. Percentage of nucleotide similarity between swine and humanHEVisolates was less than that found in countries with zoonoticHEVoutbreaks. Molecular characterization revealed the circulation of GIVand G I genotypes among swine and human population in Punjab state, respectively.